MyAverix Finance
HK · Healthcare
SinoMab BioScience Ltd (3681)
Biotechnology
SinoMab BioScience Ltd (3681) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $1.80B, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 3681
SinoMab BioScience Ltd (3681) — FAQ
What is SinoMab BioScience Ltd's market cap?
SinoMab BioScience Ltd (3681) has a reported market cap of $1.80B (data as of 2026-05-21).
What is 3681's P/E ratio?
The price-to-earnings (P/E) ratio for SinoMab BioScience Ltd (3681) is 18.00 (data as of 2026-05-21).
Does SinoMab BioScience Ltd pay a dividend?
Dividend yield is not available in the current snapshot for SinoMab BioScience Ltd (3681). Check the MyAverix Finance app for the latest dividend data.
What sector is SinoMab BioScience Ltd in?
SinoMab BioScience Ltd (3681) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 3681 listed on?
3681 is listed on HK.
What is SinoMab BioScience Ltd's net margin?
SinoMab BioScience Ltd (3681) reports a net margin of 0.0% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.